2000 CML patients to rate their care in landmark Quality-of-Life study

NCT ID NCT07165535

Recruiting now Knowledge-focused Sponsor: University of Milano Bicocca Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will ask 2000 adults with chronic myeloid leukemia (CML) in Lombardy, Italy, about their quality of life and how their hematology clinic is organized. Researchers want to see if different care models lead to better patient well-being. No new drugs or treatments are being tested—this is purely an observation and survey study.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify which care models best support CML patients' well-being, potentially improving how clinics organize follow-up care.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly lead to new therapies. Results may vary across centers and may not apply outside Lombardy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA (CML) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic myelogenous leukemia, BCR-ABL1 positive Leukemia, Myelogenous, Chronic, BCR-ABL Positive

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC MYELOID LEUKEMIA (CML)

Contacts and locations

Locations

Fondazione IRCCS San Gerardo dei Tintori
RECRUITING

Monza, MB, 20900, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.